Smithers Announces Senior Business Development Director for the Pharmaceutical Development Services

Smithers Announces Senior Business Development Director for the Pharmaceutical Development Services

Published: 2/12/2024

(Akron, OH) – February 12, 2024 - Smithers, a leading provider of testing, consulting, information, and compliance services, recently appointed Connie Scott as Senior Business Development Director of Smithers Pharmaceutical Development Services. 

Scott will be instrumental in identifying strategic business opportunities and building partnerships that align with Smithers’ vision for innovation and excellence in pharmaceutical bioanalytical development. Her expertise will be key to expanding the division’s client base and ensuring that Smithers remains at the forefront of the industry. 

Scott brings a wealth of industry knowledge and a proven track record of driving growth and fostering client relationships with a high touch in the pharmaceutical sector. Connie’s commitment to fostering strong client partnerships and her strategic acumen are in perfect harmony with Smithers’ values and mission. 

Ira DuBey, Ph.D., Chief Commercial Officer, at Smithers, expressed excitement about Connie’s arrival, saying, “Connie’s extensive experience in business development and her deep understanding of the pharmaceutical landscape make her an exceptional addition to our team. We are confident that her strategic insights and dedication to client success will foster new relationships in the biotech and biopharma spaces.” 

Located in Gaithersburg, MD and Ewing, NJ, Smithers Pharmaceutical Development Services division, a bioanalytical contract research organization (CRO), supports the development of large molecule therapeutics from discovery through phase IV, with expertise in bioassays and ultra-sensitivity ligand-binding assays. Our services focus on development, validation, and sample analysis for PK/TK, ADA, bioassays, and fit-for-purpose biomarker studies. Smithers supports the Development of biologics, monoclonal and polyclonal antibodies, bi-specific antibodies, CAR-T, TCR, and Biosimilars. Additionally, Smithers supports Cell and Gene Therapy Studies.

For more information about our CRO services, contact Connie Scott at connie.scott@smithers.com or call 240-723-0312

For more information about Smithers, please visit https://www.smithers.com/

###
About Smithers:
Founded in 1925 and headquartered in Akron, Ohio, Smithers is a multinational provider of testing, consulting, information, and compliance services. With laboratories and operations in North America, Europe, and Asia, Smithers supports customers in the transportation, life science, packaging, materials, components, consumer, cannabis, dry commodities, and energy industries. Smithers delivers accurate data, on time, with high touch, by integrating science, technology, and business expertise, so customers can innovate with confidence.

 
Cancel
Show Policy
Press-Release_Smithers-Announces-Business-Development-Director-Director-for-Pharmaceutical-Development-Services

Latest Resources

See all resources